Coronavirus: America’s drug supply needs a refill

Photo Credit: NY Daily News/Getty Images

The coronavirus outbreak that originated in China could put the health of millions of Americans at risk — but not in the way most people imagine. Since China is the world’s leading supplier of the active ingredients used in medications, the epidemic may lead to a massive shortage of prescription drugs, and generic drugs in particular.

This emerging threat sheds light on a much larger problem: America’s precarious generic-drug supply chain has made life-threatening medication shortages into a constant danger. Safeguarding access to critical medicines will require reforms that give drug manufacturers the financial incentive to keep these drugs in good supply.

Drug shortages aren’t anything new for the nation’s health system. But they have grown increasingly common in recent years. In 2019, for instance, a shortage of the childhood cancer drug vincristine jeopardized the care of young patients around the country. And the growing scarcity of the widely-used blood-thinner heparin — which is essential for performing heart surgery — has many hospitals preparing for an emergency.

 
Sign Up for Our Email Newsletter

RECENT NEWS

J&J vaccine 'safe and effective': Former FDA associate commissioner

J&J vaccine 'safe and effective': Former FDA associate commissioner

CMPI president Peter Pitts weighs in on the pause of the Johnson & Johnson vaccine across the country....  Read more

'I'm hopeful for the future': Alzheimer's drug approved by FDA

'I'm hopeful for the future': Alzheimer's drug approved by FDA

Peter Pitts of CMPI and Dr. Ronald Petersen of the Mayo Clinic discuss the FDA's approval of aducanumab...  Read more

Vaccine Passports Are ‘Reintroducing Politics into the Vaccine Conversation'

Vaccine Passports Are ‘Reintroducing Politics into the Vaccine Conversation'

A vaccine passport is not a get-out-of-pandemic card, but it could feel like one. Former FDA associate commissioner Peter...  Read more

DRUGWONKS BLOG